Jacopo Sgrignani

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

International journal of molecular sciences

bioRxiv : the preprint server for biology

Journal of medicinal chemistry

Pharmaceutics

Institute of research in biomedicine

Università di Firenze (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of research in biomedicine Sep 01 2014

Switzerland

Post-doctoral researcher

Education History

Università di Firenze Jan 01 2006 - Feb 17 2009

Italy

PHD

Publications

Marco Albani, Enrico Mario Alessandro Fassi, Roberta Manuela Moretti, Mariangela Garofalo, Marina Montagnani Marelli, Gabriella Roda, Jacopo Sgrignani, Andrea Cavalli, Giovanni Grazioso
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines. International journal of molecular sciences 25 (9) (2024)
Marco Albani, Enrico Mario Alessandro Fassi, Roberta Manuela Moretti, Mariangela Garofalo, Marina Montagnani Marelli, Gabriella Roda, Jacopo Sgrignani, Andrea Cavalli, Giovanni Grazioso
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines. International journal of molecular sciences 25 (9) (2024)
Alessandro Ratti, Enrico Mario Alessandro Fassi, Fabio Forlani, Matteo Mori, Federica Villa, Francesca Cappitelli, Jacopo Sgrignani, Gabriella Roda, Andrea Cavalli, Stefania Villa, Giovanni Grazioso
Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid. Pharmaceutics 15 (6) (2023)
Alessandro Ratti, Enrico Mario Alessandro Fassi, Fabio Forlani, Matteo Mori, Federica Villa, Francesca Cappitelli, Jacopo Sgrignani, Gabriella Roda, Andrea Cavalli, Stefania Villa, Giovanni Grazioso
Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid. Pharmaceutics 15 (6) (2023)
Alberto J Arribas, Eugenio Gaudio, Sara Napoli, Charles Jean Yvon Herbaux, Chiara Tarantelli, Roberta Pittau Bordone, Luciano Cascione, Nicolas Munz, Luca Aresu, Jacopo Sgrignani, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Andrea Cavalli, Emanuele Zucca, Georg Stussi, Anastasios Stathis, Callum Sloss, Matthew S Davids, Francesco Bertoni
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine. bioRxiv : the preprint server for biology (2023)
Filippo Bianchini, Virginia Crivelli, Morgan E Abernathy, Concetta Guerra, Martin Palus, Jonathan Muri, Harold Marcotte, Antonio Piralla, Mattia Pedotti, Raoul De Gasparo, Luca Simonelli, Milos Matkovic, Chiara Toscano, Maira Biggiogero, Veronica Calvaruso, Pavel Svoboda, Tomás Cervantes Rincón, Tommaso Fava, Lucie Podešvová, Akanksha A Shanbhag, Andrea Celoria, Jacopo Sgrignani, Michal Štefánik, Vaclav Honig, Veronika Prančlová, Tereza Michalčíková, Jan Prochazka, Giuditta Guerrini, Dora Mehn, Annalisa Ciabattini, Hassan Abolhassani, David Jarrossay, Mariagrazia Uguccioni, Donata Medaglini, Qiang Pan-Hammarström, Luigi Calzolai, Daniel Fernandez, Fausto Baldanti, Alessandra Franzetti-Pellanda, Christian Garzoni, Radislav Sedlacek, Daniel Ruzek, Luca Varani, Andrea Cavalli, Christopher O Barnes, Davide F Robbiani
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2. bioRxiv : the preprint server for biology (2022)
Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, Akanksha A Shanbhag, Milos Matkovic, Maira Biggiogero, Pier Andrea Maida, Chiara Toscano, Elaheh Ghovehoud, Gabriela Danelon-Sargenti, Tao Gong, Pietro Piffaretti, Filippo Bianchini, Virginia Crivelli, Lucie Podešvová, Mattia Pedotti, David Jarrossay, Jacopo Sgrignani, Sylvia Thelen, Mario Uhr, Enos Bernasconi, Andri Rauch, Antonio Manzo, Adrian Ciurea, Marco Bruno Luigi Rocchi, Luca Varani, Bernhard Moser, Marcus Thelen, Christian Garzoni, Alessandra Franzetti-Pellanda, Mariagrazia Uguccioni, Davide F Robbiani
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course. bioRxiv : the preprint server for biology (2022)
Enrico Mario Alessandro Fassi, Mariangela Garofalo, Jacopo Sgrignani, Michele Dei Cas, Matteo Mori, Gabriella Roda, Andrea Cavalli, Giovanni Grazioso
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity. International journal of molecular sciences 23 (9) (2022)
Sofia Spataro, Concetta Guerra, Andrea Cavalli, Jacopo Sgrignani, Jonathan Paul Sleeman, Lina Poulain, Andreas Boland, Leonardo Scapozza, Solange Moll, Marco Prunotto
CEMIP (HYBID, KIAA1199): structure, function and expression in health and disease. The FEBS journal (2022)
Ezio Bettini, Stephen M Stahl, Sara De Martin, Andrea Mattarei, Jacopo Sgrignani, Corrado Carignani, Selena Nola, Patrizia Locatelli, Marco Pappagallo, Charles E Inturrisi, Francesco Bifari, Andrea Cavalli, Andrea Alimonti, Luca Pani, Maurizio Fava, Sergio Traversa, Franco Folli, Paolo L Manfredi
Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Jacopo Sgrignani, Valentina Cecchinato, Enrico Mario Alessandro Fassi, Gianluca D'Agostino, Maura Garofalo, Gabriela Danelon, Mattia Pedotti, Luca Simonelli, Luca Varani, Giovanni Grazioso, Mariagrazia Uguccioni, Andrea Cavalli
Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction. Journal of medicinal chemistry 64 (18) (2021)
Jacopo Sgrignani, Enrico Mario Alessandro Fassi, Carmen Lammi, Gabriella Roda, Giovanni Grazioso
Exploring Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Autoproteolysis Process by Molecular Simulations: Hints for Drug Design. ChemMedChem 15 (16) (2020)
Mariangela Garofalo, Giovanni Grazioso, Andrea Cavalli, Jacopo Sgrignani
How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs. Molecules (Basel, Switzerland) 25 (7) (2020)
Carmen Lammi, Jacopo Sgrignani, Anna Arnoldi, Giordano Lesma, Claudia Spatti, Alessandra Silvani, Giovanni Grazioso
Computationally Driven Structure Optimization, Synthesis, and Biological Evaluation of Imidazole-Based Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibitors. Journal of medicinal chemistry 62 (13) (2019)
Jacopo Sgrignani, Maura Garofalo, Milos Matkovic, Jessica Merulla, Carlo V Catapano, Andrea Cavalli
Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development. International journal of molecular sciences 19 (6) (2018)
Giovanni Grazioso, Carlotta Bollati, Jacopo Sgrignani, Anna Arnoldi, Carmen Lammi
First Food-Derived Peptide Inhibitor of the Protein-Protein Interaction between Gain-of-Function PCSK9D374Y and the Low-Density Lipoprotein Receptor. Journal of agricultural and food chemistry 66 (40) (2018)
Alessandra Magistrato, Jacopo Sgrignani, Rolf Krause, Andrea Cavalli
Single or Multiple Access Channels to the CYP450s Active Site? An Answer from Free Energy Simulations of the Human Aromatase Enzyme. The journal of physical chemistry letters 8 (9) (2017)

Jacopo Sgrignani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jacopo Sgrignani